ZETAMET™ BONE GRAFT IN THE REPAIR OF BONE DEFECTS FROM METASTATIC BREAST CANCER IN VERTEBRAL BONES
Clinical trial NCT05280067 · COMPLETED
Trial details
- NCT number
- NCT05280067
- Sponsor
- Zetagen Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2025-10-10
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.